Add the Russia-Ukraine war to the potential challenges facing Asensus Surgical (NYSE American: ASXC) as it seeks to innovate in the surgical robotics space. Research Triangle Park, North Carolina–based Asensus today announced the sale of one of its Senhance surgical systems, an important development given that its 2021 annual report lists a total of two […]
J&J’s Acclarent wins FDA clearance for navigated shaver blade for ENT procedures
Johnson & Johnson MedTech’s Acclarent business announced FDA 510(k) clearance for its TruDi shaver blade and its advanced navigation features. In a news release posted yesterday, Acclarent described TruDI as a single-use electromagnetically navigated blade. It’s used with the company’s Bien-Air S120 shaver for the incision and removal of soft and hard tissue or bone […]
Abiomed scales back revenue guidance amid strong dollar
Abiomed (Nasdaq: ABMD) today reported Q1 earnings that beat The Street, but the company is scaling back revenue projections amid tough foreign exchange rates for U.S. companies. The Danvers, Mass.–based maker of circulatory and oxygenation support devices earned $54.6 million, or $1.19 per share, off $277.1 million in sales for the quarter ended June 30, […]
Enovis more than doubles earnings in Q2, scales back EPS guidance
Enovis (NYSE: ENOV) today reported Q2 results that beat The Street on earnings but missed on revenue, with the ortho device company joining the host of medtech companies scaling back earnings projections for the year amid macroeconomic headwinds. Wilmington, Delaware–based Enovis — the parent company of DJO — earned $121 million, or $2.21 per diluted […]
BD beats The Street in Q3, raises guidance
BD (NYSE: BDX) today announced third-quarter results that beat the consensus forecast on Wall Street and raised both its revenue and EPS guidance, even as management acknowledged a challenging macroeconomic environment. The Franklin Lakes, N.J.–based medtech giant earned $360 million, or $1.28 per share, off $4.64 billion in sales for the quarter ended June 30, […]
Zimmer Biomet speeds up investments in NeuroOne
NeuroOne Medical Technologies (Nasdaq: NMTC) announced today that it will receive an accelerated $3.5 million milestone payment from Zimmer Biomet. The milestone payment is related to Eden Prairie, Minnesota–based NeuroOne’s Evo sEEG electrode technology, which last year received FDA 510(k) clearance for temporary (less than 24 hours) recording, monitoring and stimulation of electrical signals at […]
Inspire Medical Systems revenue up 71% in Q2
Inspire Medical Systems (NYSE: INSP) easily blew past Wall Street predictions in Q2, though the company is scaling back its gross margin projections. Minneapolis-based Inspire Medical is the maker of a minimally-invasive, implantable, pacemaker-like device that uses neurostimulation to treat obstructive sleep apnea. It announced yesterday evening that it lost $14.5 million, or 53¢ per […]
ResMed acquires Mementor and its digital health app for insomnia
ResMed (NYSE: RMD, ASX: RMD) announced today that it has acquired Mementor (Leipzig) and its digital insomnia therapy in a bid to strengthen its overall sleep portfolio in Germany. The deal closed yesterday. ResMed did not disclose financial terms. The maker of CPAPs and other respiratory therapy devices was one of the first medical device […]
Zimmer Biomet scores a big earnings beat in Q2
Zimmer Biomet (NYSE and SIX: ZBH) today reported second-quarter results that handily beat the consensus forecast on Wall Street, upping its full-year forecast for 2022. Investors reacted by sending ZBH shares up more than 5% to $115.93 apiece in morning trading. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, […]
Henry Schein names C-level executive to drive e-commerce
Henry Schein (Nasdaq: HSIC) announced today that it’s appointed Mark Hillebrandt to the role of VP and chief digital revenue officer, leading a new Digital Revenue Team to boost e-commerce revenues. Mark Hillebrandt has held executive roles at Henry Schein since 2018. Previous positions included nearly three years as business leader for Amazon’s professional dental, […]
Edwards Lifesciences misses in Q2, lowers guidance
Edwards Lifesciences (NYSE:EW) shares are down after hours on second-quarter results that missed the consensus forecast on Wall Street, with the cardio device company reducing 2022 guidance amid foreign exchange headwinds and hospital staffing challenges. The Irvine, California–based company earned $406.4 million, or 65¢ per share, off $1.37 billion for the three months ended June […]